The Ankylosing Spondylitis Quality of Life Questionnaire: validation in a New Zealand cohort

Jenks, Katherine; Treharne, Gareth J.; García, José; Stebbings, Simon

doi:10.1111/j.1756-185x.2010.01554.x

Cited by 15 publications

(10 citation statements)

References 13 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are several other reports indicating a negative effect of pain severity on QoL in AS. 3,27,33,34,36,37 It is widely accepted that acute phase reactants, ESR, and CRP do not reflect the clinical course entirely in AS. Normal values of these parameters do not eliminate the active disease.…”

Section: Discussionmentioning

confidence: 99%

Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study

Öncülokur¹

2018

Arch Rheumatol

View full text Add to dashboard Cite

Objectives: This study aims to translate the Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL) into the Turkish language and test its validity and reliability. Patients and methods: A total of 100 AS patients (74 males; 26 females; mean age 38.2±9.9 years; range 21 to 63 years) were included. The mean disease duration was 115.9±91.6 months. EASi-QoL was translated from English into Turkish, and synthesis, back translation, revision, and pretest stages were performed. All patients were asked to complete the Turkish version of EASi-QoL. The internal consistency of EASi-QoL was determined with Cronbach's alpha coefficient, and test-retest reliability was assessed by calculating the intra-class correlation coefficient. Confirmatory and explanatory factor analyses were performed to assess structural validity. Construct validity was also investigated by comparing the results of EASi-QoL with the

show abstract

Section: Discussionmentioning

confidence: 99%

Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study

Öncülokur¹

2018

Arch Rheumatol

View full text Add to dashboard Cite

show abstract

“…Interestingly, her AS also showed improvements based on ASQoL: her ASQoL score decreased from 18 down to 3 after SVF treatment. We used the ASQoL to assess our patient’s AS; the ASQoL questionnaire is a feasible method of determining a patient’s quality of life [ 15 ].…”

Section: Discussionmentioning

confidence: 99%

Ankylosing spondylitis, chronic fatigue and depression improved after stromal vascular fraction treatment for osteoarthritis: a case report

Bright

et al. 2018

J Med Case Reports

View full text Add to dashboard Cite

BackgroundOsteoarthritis is a prevalent chronic disease that impacts quality of life and imposes a heavy economic burden. Despite this there is no confirmed treatment that could prevent progressive destruction of osteoarthritic joints. Mesenchymal stem cells with their regenerative and immunosuppressive properties have emerged as a potential therapy.Case presentationThis case study describes the impact of autologous adipose-derived stromal vascular fraction treatment on a 27-year-old Australian woman with osteoarthritis and multiple comorbidities of ankylosing spondylitis, chronic pain syndrome, and post-traumatic stress disorder as assessed by magnetic resonance imaging, Western Ontario and McMaster Universities Osteoarthritis Index, and Hip Disability and Osteoarthritis Outcome Score. Following standardized stromal vascular fraction treatment protocols for osteoarthritis of her hips and knee, the functional status of her hips was measured by Hip Disability and Osteoarthritis Outcome Score at 3 months, 6 months, and 3 years.ConclusionsOur patient showed dramatic improvements to her quality of life and symptoms of osteoarthritis were reduced. Interestingly, along with improvements in her knee and hips her other comorbidities such as ankylosing spondylitis, depression, anxiety, and fatigue exhibited marked improvement. She ceased the use of a wheelchair and walking support and, with increased mobility, had gained independence. These findings are suggestive of the therapeutic effects of stromal vascular fraction.

show abstract

“…The original UK English ASQ O L continues to be translated and validated in other languages, including US English, Canadian French and English, German, Italian, Spanish, Swedish (17), French (17, 18), Chinese (19), Hungarian (20) and Turkish (17, 21). It has also been validated in patients with axial spondylarthritis (22).…”

Section: Ankylosing Spondylitis Quality Of Life Scale (Asqol)mentioning

confidence: 99%

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS‐G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ‐S)

Zochling

2011

Arthritis Care & Research

267

View full text Add to dashboard Cite

The Ankylosing Spondylitis Quality of Life Questionnaire: validation in a New Zealand cohort

Abstract: The ASQoL has been demonstrated in this study to be feasible, internally consistent and to have content and convergent validity in a New Zealand population of patients with axial spondyloarthritis; it is a measure of quality of life which is both easy to employ and reliable.

Cited by 15 publications

References 13 publications

Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study

Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study

Ankylosing spondylitis, chronic fatigue and depression improved after stromal vascular fraction treatment for osteoarthritis: a case report

Contact Info

Product

Resources

About